Nfocus neuromedical inc said it received the ce mark for its stent-graft and delivery system, trademarked cardiovasc.
This is a minimally invasive device for treating patients with saphenous vein graft lesions (SVGs) from a previous coronary bypass, vessel perforations and coronary artery aneurysms.
This is the first in, what company Chief Executive Martin Dieck hopes, is a series of regulatory approvals in the coming year.
The ...